Preoperative Radiochemotherapy in Esophageal Squamous Cell Cancer with 5-Fluorouracil/Cisplatin or Carboplatin/Paclitaxel: Treatment Practice over a 20-Year Period and Implications for the Individual Treatment Modalities

Preoperative Radiochemotherapy in Esophageal Squamous Cell Cancer with 5-Fluorouracil/Cisplatin or Carboplatin/Paclitaxel: Treatment Practice over a 20-Year Period and Implications for the Individual Treatment Modalities

We retrospectively studied outcomes in patients treated with preoperative radiochemotherapy and surgery for esophageal squamous cell cancer. We put special focus on the comparison of patients treated with 5-fluorouracil/cisplatin (‘Walsh’) or carboplatin/paclitaxel (‘CROSS’). We compared characteris...

Full description

Bibliographic Details
Main Authors: Leif Hendrik Dröge, Philipp Johannes Karras, Manuel Guhlich, Markus Anton Schirmer, Michael Ghadimi, Stefan Rieken, Lena-Christin Conradi, Martin Leu
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Cancers
Subjects:
esophageal cancer
preoperative radiochemotherapy
chemotherapy regimen
acute toxicity
hematologic toxicity
complications
Online Access:https://www.mdpi.com/2072-6694/13/8/1834

Internet

https://www.mdpi.com/2072-6694/13/8/1834

Similar Items